Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone
Author(s) -
A. Dahmane,
Johan van Griensven,
Michel Van Herp,
Rafaël Van den Bergh,
Yvonne Nzomukunda,
Jerilynn C. Prior,
P. Alders,
Amara Jambai,
Rony Zachariah
Publication year - 2014
Publication title -
transactions of the royal society of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 105
eISSN - 1878-3503
pISSN - 0035-9203
DOI - 10.1093/trstmh/tru009
Subject(s) - lassa fever , medicine , ribavirin , case fatality rate , sierra leone , pediatrics , referral , emergency medicine , epidemiology , disease , family medicine , virology , virus , development economics , economics , hepatitis c virus
Lassa fever (LF) is an acute viral haemorrhagic infection, endemic in West Africa. Confirmatory diagnosis and treatment (ribavirin) is difficult, expensive, and restricted to specialised hospitals. Among confirmed and suspected LF cases, we report on clinical and laboratory features, timing and administration of ribavirin and the relationship with case fatality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom